Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

417 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.
Hanahan D, Folkman J. Hanahan D, et al. Cell. 1996 Aug 9;86(3):353-64. doi: 10.1016/s0092-8674(00)80108-7. Cell. 1996. PMID: 8756718 Review. No abstract available.
The hallmarks of cancer.
Hanahan D, Weinberg RA. Hanahan D, et al. Cell. 2000 Jan 7;100(1):57-70. doi: 10.1016/s0092-8674(00)81683-9. Cell. 2000. PMID: 10647931 Review. No abstract available.
Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally.
Olson DC, Deng C, Hanahan D. Olson DC, et al. Among authors: hanahan d. Cell Growth Differ. 1998 Jul;9(7):557-64. Cell Growth Differ. 1998. PMID: 9690623
Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
Bergers G, Hanahan D, Coussens LM. Bergers G, et al. Among authors: hanahan d. Int J Dev Biol. 1998;42(7):995-1002. Int J Dev Biol. 1998. PMID: 9853830 Review.
Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.
Onrust SV, Hartl PM, Rosen SD, Hanahan D. Onrust SV, et al. Among authors: hanahan d. J Clin Invest. 1996 Jan 1;97(1):54-64. doi: 10.1172/JCI118406. J Clin Invest. 1996. PMID: 8550850 Free PMC article.
Signaling vascular morphogenesis and maintenance.
Hanahan D. Hanahan D. Science. 1997 Jul 4;277(5322):48-50. doi: 10.1126/science.277.5322.48. Science. 1997. PMID: 9229772 No abstract available.
Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis.
Hager JH, Hanahan D. Hager JH, et al. Among authors: hanahan d. Ann N Y Acad Sci. 1999;887:150-63. doi: 10.1111/j.1749-6632.1999.tb07929.x. Ann N Y Acad Sci. 1999. PMID: 10668471 Review.
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.
Hanahan D, Christofori G, Naik P, Arbeit J. Hanahan D, et al. Eur J Cancer. 1996 Dec;32A(14):2386-93. doi: 10.1016/s0959-8049(96)00401-7. Eur J Cancer. 1996. PMID: 9059326 Review. No abstract available.
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
Naik P, Karrim J, Hanahan D. Naik P, et al. Among authors: hanahan d. Genes Dev. 1996 Sep 1;10(17):2105-16. doi: 10.1101/gad.10.17.2105. Genes Dev. 1996. PMID: 8804306
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D. Parangi S, et al. Among authors: hanahan d. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2002-7. doi: 10.1073/pnas.93.5.2002. Proc Natl Acad Sci U S A. 1996. PMID: 8700875 Free PMC article.
417 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback